SciELO - Scientific Electronic Library Online

 
vol.100 issue5Biosafety measures against COVID-19 applied in the care of maxillofacial emergencies author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Información Científica

On-line version ISSN 1028-9933

Abstract

DIAZ-ARMAS, María Teresa; SANCHEZ-ARTIGAS, Rolando; MATUTE-CRESPO, Tamia Zaadé  and  LLUMIQUINGA-ACHI, Ronny Alexander. Spike protein of the SARS-CoV-2 virus and its relationship with the angiotensin-converting enzyme-2. Rev. inf. cient. [online]. 2021, vol.100, n.5  Epub Sep 04, 2021. ISSN 1028-9933.

Introduction:

COVID-19 caused by the SARS-CoV-2 virus is a pandemic that has claimed the lives of millions of people and overloaded health services around the world.

Objective:

To describe the relationship between the spike protein (S) of SARS-CoV-2 and the angiotensin-converting enzyme 2 as the primary trigger of COVID-19 infection.

Method:

A bibliographic search was carried out in Google Scholar, SciELO and PubMed, with the initial descriptors COVID-19 and SARS-CoV-2. The publication period selected was between the years 2019 to 2021, without restrictions regarding the type of article. The papers had to be available in full text in Spanish and English.

Results:

The spike protein of SARS-CoV-2, which plays a key role in receptor recognition and in the cell membrane fusion process, is composed of two subunits, S1 and S2. The S1 subunit contains a receptor-binding domain (RBD) that binds to the host's receptor, angiotensin-converting enzyme 2, while the S2 subunit is involved in the viral and cellular membrane fusion. The tissue ubiquity of angiotensin converting enzyme 2 explains the multiple clinical manifestations of the disease.

Conclusions:

The knowledge of the relationship between SARS-CoV-2 and its receptor the angiotensin-converting enzyme 2, allows not only to know the pathophysiology of COVID-19, but also the design of antiviral drugs and vaccines that contribute to the prevention and treatment of this viral disease.

Keywords : COVID-19; SARS-CoV-2; spike protein; angiotensin converting enzyme 2; vaccines.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )